Nelboeck P, Fuchs M, Bur D, Löffler B M
F. Hoffmann-La Roche Ltd., Pharma Division, Preclinical Research, Basel, Switzerland.
J Cardiovasc Pharmacol. 1998;31 Suppl 1:S4-6. doi: 10.1097/00005344-199800001-00003.
It has been shown previously that N-glycosylation of Asn-144 and/or Asn-627 is important for functional expression of neutral endopeptidase-24.11 (NEP). All glycosylation sites of NEP are conserved within endothelin-converting enzyme-1 (ECE-1). In the present study we investigated the importance of proper glycosylation for the biologic function of ECE-1. We show that the double mutation of Asn-632 and Asn-651 leads to expression of an enzymatically inactive ECE-1 protein. In contrast, the single mutation of either Asn-632 or Asn-651 did not alter the enzymatic activity of ECE-1b.
先前已表明,天冬酰胺-144和/或天冬酰胺-627的N-糖基化对于中性内肽酶-24.11(NEP)的功能表达很重要。NEP的所有糖基化位点在内皮素转换酶-1(ECE-1)中都是保守的。在本研究中,我们研究了正确糖基化对ECE-1生物学功能的重要性。我们发现,天冬酰胺-632和天冬酰胺-651的双突变导致酶活性失活的ECE-1蛋白的表达。相反,天冬酰胺-632或天冬酰胺-651的单突变并未改变ECE-1b的酶活性。